Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07435207

Thrombotic RIsk FActors in AL-goneurodystrophy

The primary objective of the study is to evaluate the prevalence of blood prothrombotic factors in CRPS patients and their role in predicting response to neridronic acid treatment.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Algoneurodystrophy

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondazione IRCCS Policlinico San Matteo di Pavia

Pavia, 27100, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical (according to Budapest clinical diagnostic criteria for CRPS)

  • patients aged 18 years or more

Exclusion criteria

patients unable to give consent

-

Treatment and study plan

Primary outcomes

  1. Pain VAS

    Time frame: 1,3 and 6 months after therapy

    change in Pain VAS

Sponsors and collaborators

Lead sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Other

Registry information

Acronym: TRIF-AL

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Feb 27, 2026
Registry last updated
Feb 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.